These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 993113)

  • 21. [Screening of antineoplastic antibiotics by means of the phage induction method].
    Fadeeva NP; Terent'eva TG; Singal EM; Solov'eva NK; Efimova TN
    Antibiotiki; 1971 Mar; 16(3):236-9. PubMed ID: 5109159
    [No Abstract]   [Full Text] [Related]  

  • 22. [On a new antibiotic of streptomycetic origin active against Ehrlich's ascitic carcinoma].
    Bertelli A; Bonmassar E; Montagnani-Marelli A; Zannini E
    Arch Ital Patol Clin Tumori; 1967; 10(1):21-8. PubMed ID: 5600138
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661].
    Rossolimo OK; Ivanitskaia LP; Kovsharova IN; Konstantinova NV; Lavrova MF
    Antibiotiki; 1969 Sep; 14(9):849-52. PubMed ID: 4982966
    [No Abstract]   [Full Text] [Related]  

  • 24. Identity of antibiotic P-42-1 elaborated by Actinomyces tumemacerans with kanchanomycin and albofungin.
    Fukushima K; Ishiwata K; Kuroda S; Arai T
    J Antibiot (Tokyo); 1973 Feb; 26(2):65-9. PubMed ID: 4781285
    [No Abstract]   [Full Text] [Related]  

  • 25. Renastacarcin, a novel antitumor substance produced by Streptomyces.
    Sasaki T; Otake N
    J Antibiot (Tokyo); 1975 Jul; 28(7):552-4. PubMed ID: 1150546
    [No Abstract]   [Full Text] [Related]  

  • 26. A new antibiotic, leucinostatin, derived from Penicillium lilacinum.
    Arai T; Mikami Y; Fukushima K; Utsumi T; Yazawa K
    J Antibiot (Tokyo); 1973 Mar; 26(3):157-61. PubMed ID: 4783199
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological activities of IC201 ((3S,8E)-1,3-dihydroxy-8-decen-5-one), a low molecular weight immunomodulator produced by Streptomyces.
    Mizutani S; Odai H; Masuda T; Iijima M; Osono M; Hamada M; Naganawa H; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1989 Jun; 42(6):952-9. PubMed ID: 2786863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental study of purified neocid].
    Derkach VS
    Antibiotiki; 1966 Jul; 11(7):619-21. PubMed ID: 5997586
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on a new antitumor antibiotic, largomycin. 3. Biological properties and antitumor activity of largomycin F-II.
    Yamaguchi T; Seto M; Oura Y; Arai Y; Enomoto K
    J Antibiot (Tokyo); 1970 Aug; 23(8):382-7. PubMed ID: 5453314
    [No Abstract]   [Full Text] [Related]  

  • 30. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
    Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on a new antibiotic M-92 produced by Micromonospora. III. Biological activities.
    Tani K; Arai Y; Yamaguchi T
    J Antibiot (Tokyo); 1982 Nov; 35(11):1441-7. PubMed ID: 7161183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new antibiotic, 1-(p-hydroxyphenyl)-2,3-diisocyano-4-(p-methoxyphenyl)-buta-1,3-diene. I. Isolation and biological properties. (Studies on antiviral and antitumor antibiotics. II).
    Ando K; Suzuki S; Takatsuki A; Arima K; Tamura G
    J Antibiot (Tokyo); 1968 Oct; 21(10):582-6. PubMed ID: 4975360
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor activity of a new antibiotic, kazusamycin.
    Komiyama K; Okada K; Hirokawa Y; Masuda K; Tomisaka S; Umezawa I
    J Antibiot (Tokyo); 1985 Feb; 38(2):224-9. PubMed ID: 3922935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antineoplastic effect of antibiotics 3002 and 3853].
    Rossolimo OK; Maksimova TS; Sveshnikova MA; Ol'khovatova OL; Kovsharova IN
    Antibiotiki; 1971; 16(4):320-2. PubMed ID: 5109579
    [No Abstract]   [Full Text] [Related]  

  • 35. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. V. Production, characterization and antitumor activity of tallysomycin S10b, a new biosynthetic tallysomycin derivative.
    Miyaki T; Numata K; Nishiyama Y; Tenmyo O; Hatori M; Imanishi H; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1981 Jun; 34(6):665-74. PubMed ID: 6168631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of new analogues of verrucarin E on the growth of Ehrlich ascites carcinoma in mice].
    Myrcik H; Piotrowska-Olczak H
    Patol Pol; 1974; 25(1):15-9. PubMed ID: 4827993
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various aspects of the biological effects of substances formed by Pseudomonas sp].
    Kiprianova OA; Rabinovich AS; Mandrik TP; Shvaĭer MO; Mil'chenko KP
    Mikrobiol Zh; 1969; 31(6):573-5. PubMed ID: 5405246
    [No Abstract]   [Full Text] [Related]  

  • 38. Arugomycin, a new anthracycline antibiotic.
    Kawai H; Hayakawa Y; Nakagawa M; Imamura K; Tanabe K; Shimazu A; Seto H; Otake N
    J Antibiot (Tokyo); 1983 Nov; 36(11):1569-71. PubMed ID: 6651934
    [No Abstract]   [Full Text] [Related]  

  • 39. [High molecular weight antineoplastic antibiotics of a polypeptide or protein nature formed by Actinomycetes].
    Kuimova TF
    Antibiotiki; 1966 Jul; 11(7):651-6. PubMed ID: 5997589
    [No Abstract]   [Full Text] [Related]  

  • 40. Antitumor activity of a new antitumor antibiotic, stubomycin.
    Komiyama K; Edanami K; Yamamoto H; Umezawa I
    J Antibiot (Tokyo); 1982 Jun; 35(6):703-6. PubMed ID: 7118726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.